Personalized, compounded tirzepatide — flexible dosing from a US-licensed pharmacy. See pricing

Get started on Personalized Tirzepatide, if prescribed
compounded · dual GIP/GLP-1
A compounded tirzepatide program with flexible, personalized dosing, prepared by a US-licensed compounding pharmacy and overseen by your clinician. Compounded tirzepatide is not FDA-approved.
Zepbound is the brand-name, FDA-approved tirzepatide. Compounded tirzepatide is prepared by a compounding pharmacy and allows flexible dosing, but it has not been through FDA approval. The FDA does not review compounded medications for safety, effectiveness, or quality; they are prepared by licensed pharmacies for patients with a clinical need identified by their clinician.
What’s similar
What’s different
One-time orders, priced by the pharmacy you choose plus the Body Good flat fee. You see both, and the total, before you pay. A prescription is required, and a clinician must approve your plan and doses before anything ships.
Prescription only. Your clinician determines the medicine and the dose after reviewing your health history — you state a preference, and the clinician may prescribe something different, or nothing at all.
Compounded medications are not FDA-approved, and published trial results for branded medicines do not describe compounded formulations. Prescriptions are issued only after a licensed clinician reviews your health history, and only where clinically appropriate.
Safety info: Compounded tirzepatide is not FDA-approved — see safety information. See more serious warnings & safety info
The science behind the molecule
~21%

studied for branded tirzepatide*
Tirzepatide, the active ingredient, helped adults lose about 21% of their body weight at the highest dose in the SURMOUNT-1 study of the FDA-approved brand. These figures reflect the branded, FDA-approved medication — not compounded tirzepatide, which the FDA has not evaluated for safety, effectiveness, or quality.*
Semaglutide vs. tirzepatide
In SURMOUNT-5, the first study to compare the two medicines directly, adults on tirzepatide lost more weight on average than those on semaglutide over 72 weeks.
TirzepatideZepbound / Mounjaro
−20.2%
SemaglutideWegovy / Ozempic
−13.7%
SURMOUNT-5: a 72-week randomized study comparing maximum-tolerated tirzepatide (10/15 mg) with maximum-tolerated semaglutide (1.7/2.4 mg). Mean weight change was −20.2% with tirzepatide vs −13.7% with semaglutide. Both are effective, FDA-approved options; the right one for you is a clinical decision. Individual results vary.
Meet
Why members choose it
Personalized, supported, flexible
Personalized dosing
Your clinician tailors your titration schedule to how you respond.
Clear one-time pricing
Priced by the pharmacy you choose plus the Body Good flat fee. You see both, and the total, before you pay.

Real clinical support
A licensed clinician oversees your plan and answers questions anytime.
−20.9% average
tirzepatide 15 mg weekly, 72 weeks (SURMOUNT-1) — a trial average, not a prediction of your result

100% online. Zero waiting rooms.
From the first visit to insurance support, we help you get — and stay — on track.
Start in 3 simple steps
One-time · priced by your pharmacy
One-time orders, priced by the pharmacy you choose plus the Body Good flat fee. Pick your dose and the state your order ships to, then a pharmacy that ships there. You see both prices, and the total, before you pay.
Each order is one-time: a single shipment, charged once. You see the pharmacy price, the Body Good flat fee and the total before you pay.
Choose your starting dose
You select your starting dose upfront; your clinician confirms it and your titration.
Not FDA-approved. Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality. Any weight-loss figures shown reflect studies of the branded, FDA-approved medications (Wegovy, Zepbound) and do not establish the safety or effectiveness of any compounded product. Compounding is intended for patients with a specific clinical need identified by their clinician.
Choose how you pay
Pick your dose, where it ships, and the pharmacy that fills it.
Loading prices…
One-time orders, priced by the pharmacy you choose plus the Body Good flat fee. You see both, and the total, before you pay. A prescription is required, and a clinician must approve your plan and doses before anything ships. Your dose is selected now; your clinician reviews and can adjust before dispensing.
Women on Personalized Tirzepatide
Paid testimonials. Results have not been independently verified. Individual results will vary.


Dr. Linda Moleon — founder, Obesity Medicine Specialist. The same clinicians build your plan, file your prior authorization, and follow you refill after refill, in English and Spanish.
Meet the care team
No. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality. They are prepared by licensed pharmacies for patients with a clinical need identified by their clinician.
Zepbound is the brand-name, FDA-approved tirzepatide. Compounded tirzepatide is prepared by a compounding pharmacy and allows flexible dosing, but it has not been through FDA approval.
The figures shown come from studies of the branded, FDA-approved medication and do not establish the safety or effectiveness of any compounded product. Individual results vary.
In the head-to-head SURMOUNT-5 study of the branded medicines, tirzepatide produced greater average weight loss (−20.2% vs −13.7%). Your clinician helps you choose.
As with branded tirzepatide, most common are nausea, diarrhea, vomiting, and constipation. See full safety information below.
Flexible dosing, one-time orders priced by your pharmacy, real clinical support. A prescription is required.
Get startedWhat you should know before taking Personalized Tirzepatide.
Boxed Warning: Risk of thyroid C-cell tumors. In animal studies, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use if you or any family member have ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are allergic to tirzepatide.
Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality. Any weight-loss figures shown reflect studies of the branded, FDA-approved medications (Wegovy, Zepbound) and do not establish the safety or effectiveness of any compounded product. Compounding is intended for patients with a specific clinical need identified by their clinician.
Tirzepatide It may cause serious side effects, including inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar, kidney problems, and serious allergic reactions. The most common side effects are gastrointestinal — nausea, diarrhea, vomiting, and constipation. Tell your clinician about all your medical conditions and medications.
This page is for informational purposes and is not medical advice. Talk to a licensed clinician about whether this treatment is right for you. For full prescribing information and the Medication Guide, see the manufacturer's official materials.